Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Buy
15,847
+1,532
+11% +$179K 0.67% 45
2026
Q1
$1.72M Buy
+14,315
New +$1.65M 0.6% 52
2025
Q4
Sell
-3,910
Closed -$328K 207
2025
Q3
$328K Buy
3,910
+1
+0% +$82 0.11% 171
2025
Q2
$309K Sell
3,909
-1,113
-22% -$88.5K 0.11% 172
2025
Q1
$451K Sell
5,022
-158
-3% -$14.8K 0.17% 140
2024
Q4
$515K Sell
5,180
-45
-0.9% -$4.64K 0.2% 128
2024
Q3
$556K Buy
+5,225
New +$621K 0.2% 130
2023
Q2
$3.65M Buy
31,608
+429
+1% +$48.7K 1.24% 23
2023
Q1
$3.32M Buy
31,179
+1,426
+5% +$154K 1.12% 21
2022
Q4
$3.3M Buy
29,753
+4,098
+16% +$419K 1.14% 21
2022
Q3
$2.21M Buy
25,655
+3,414
+15% +$305K 0.91% 27
2022
Q2
$2.03M Buy
22,241
+2,073
+10% +$184K 0.78% 29
2022
Q1
$1.66M Buy
20,168
+15,479
+330% +$1.22M 0.6% 45
2021
Q4
$359K Sell
4,689
-2,290
-33% -$182K 0.12% 131
2021
Q3
$524K Buy
6,979
+2,141
+44% +$163K 0.2% 100
2021
Q2
$376K Buy
4,838
+2,018
+72% +$150K 0.14% 126
2021
Q1
$207K Sell
2,820
-6,594
-70% -$486K 0.09% 151
2020
Q4
$735K Buy
+9,414
New +$720K 0.33% 67

Other funds holding MRK

44 Wealth Management's MRK Position: Q2 2026 in Review

44 Wealth Management increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $179K and bringing the position to 15,847 shares worth $2.04M. The position accounts for 0.67% of the portfolio, ranked #45.

44 Wealth Management first reported a position in MRK in Q4 2020 and has held it in 18 quarters since. The position peaked at $3.65M in Q2 2023. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • 44 Wealth Management held 15,847 shares of Merck worth $2.04M as of Q2 2026.
  • 44 Wealth Management bought 1,532 Merck shares in Q2 2026, an estimated $179K.
  • Merck made up 0.67% of 44 Wealth Management's portfolio in Q2 2026, its #45 holding.
  • 44 Wealth Management first reported a position in Merck in Q4 2020 and has held it in 18 quarters since.
  • 44 Wealth Management's Merck position peaked at $3.65M in Q2 2023.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on 44 Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.